Andrés López

Universidad Técnica de Ambato — EC

Medicine · Health Sciences

16h-index822citations62works0.62yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Lymphoma Diagnosis and Treatment(39), Chronic Lymphocytic Leukemia Research(21), Viral-associated cancers and disorders(19), CNS Lymphoma Diagnosis and Treatment(8), Neutropenia and Cancer Infections(6)

Publications62 total

Allogenic Transplantation in Cutaneous T-cell lymphoma
European Journal of Cancer·2025
Comparación de índices antropométricos con relación a los niveles de actividad física en estudiantes universitarios
Revista Ecos de la Academia·2025Open Access
306 | CENTRAL NERVOUS SYSTEM RELAPSE IN HIGH‐GRADE B‐CELL LYMPHOMA WITH MYC AND BCL2 AND/OR BCL6 REARRANGEMENTS: A MULTICENTER STUDY FROM THE SPANISH GROUP GELTAMO
Hematological Oncology·2025Open Access
Clinical Characteristics and Outcomes of Patients with Localized Stage High-Grade B-Cell Lymphoma (HGBCL) with or without MYC and BCL2 and/or BCL6 Rearrangements: A Retrospective Study from the Spanish Group Geltamo
Blood·2024Open Access
21195. EXPERIENCIA CON EPTINEZUMAB EN MIGRAÑA CRÓNICA EN HOSPITALES DE NUESTRA PROVINCIA
Neurology Perspectives·2024Open Access
982 - ANÁLISIS DE LOS FACTORES DE RIESGO Y DE MAL PRONÓSTICO DEL SÍNDROME HEMOFAGOCÍTICO EN ADULTOS A PARTIR DE UNA SERIE DE CASOS
Revista Clínica Española·2024Open Access
347 - ESTUDIO DESCRIPTIVO DE LA ENFERMEDAD DE WERNICKE EN UN HOSPITAL DE TERCER NIVEL EN LOS ÚLTIMOS TRES AÑOS
Revista Clínica Española·2024
550 - COMPARACIÓN DE LA ENFERMEDAD DE WERNICKE EN PACIENTES CON CONSUMO DE ALCOHOL FRENTE A OTROS FACTORES DE RIESGO, ¿EXISTEN DIFERENCIAS?
Revista Clínica Española·2024
Promoción y desarrollo de capacitaciones y su incidencia en el fortalecimiento de las capacidades empresariales, emprendedoras y productivas en la mancomunidad del Pacifico Norte (Manpanorte)
Revista Conocimiento Global.·2024Open Access
The Effect of First Metatarsal Shortening and Sagittal Displacement on Forefoot Pressure in Minimally Invasive Hallux Valgus Correction
Foot & Ankle Specialist·2024· 4 citedOpen Access
The Effect of First Metatarsal Shortening and Sagittal Displacement on Forefoot Pressure in MIS Hallux Valgus Correction
Foot & Ankle Orthopaedics·2024Open Access
Functional assessment of a whey protein hydrolysate: In vivo responses in lipid regulation, oxidant defense, and neural protection in Caenorhabditis elegans
International Dairy Journal·2024· 3 cited
Novel therapies for the treatment of relapsed‐refractory aggressive B‐cell lymphoma increase survival. Analysis from the RELINF registry of the GELTAMO group
Hematological Oncology·2023Open Access
<i>BCL2</i> translocation in high grade B cell lymphoma (NOS, DH/TH) is associated with reduced progression free survival
Leukemia & lymphoma/Leukemia and lymphoma·2021· 6 cited
A randomized phase II study comparing consolidation with a single dose of <sup>90</sup>Y ibritumomab tiuxetan <i>vs.</i> maintenance with rituximab for two years in patients with newly diagnosed follicular lymphoma responding to R-CHOP. Long-term follow-up results
Leukemia & lymphoma/Leukemia and lymphoma·2021· 11 cited
CENTRAL NERVOUS SYSTEM RELAPSE IN PATIENTS WITH DIFFUSE LARGE B‐CELL LYMPHOMA TREATED WITH R‐CHOP: STUDY OF THE SPANISH LYMPHOMA GROUP GELTAMO
Hematological Oncology·2021Open Access
Long-term follow-up of a prospective phase 2 clinical trial of extended treatment with rituximab in patients with B cell post-transplant lymphoproliferative disease and validation in real world patients
Annals of Hematology·2020· 13 cited
RELINF: prospective epidemiological registry of lymphoid neoplasms in Spain. A project from the GELTAMO group
Annals of Hematology·2020· 34 cited
Evaluation of the MD Anderson tumor score for diffuse large B‐cell lymphoma in the rituximab era
European Journal Of Haematology·2019· 3 citedOpen Access
Response‐adapted treatment with rituximab, bendamustine, mitoxantrone, and dexamethasone followed by rituximab maintenance in patients with relapsed or refractory follicular lymphoma after first‐line immunochemotherapy: Results of the RBMDGELTAMO08 phase II trial
Cancer Medicine·2019· 5 citedOpen Access
page 1 of 4Next →

Frequent Co-authors

Eva González‐Barca(16), Antonio Salar(12), Carlos Montalbán(10), Alejandro Martı́n(10), Juan‐Manuel Sancho(10), Miguel Canales(8), Sonia González de Villambrosía(8), Armando López‐Guillermo(8), Pau Abrisqueta(8), Miguel Á. Piris(7), Juan F. Garcı́a(6), Antonio Gutiérrez(6), Dolores Caballero(6), Santiago Gardella(5), Santiago Montes‐Moreno(5), Beatriz Sánchez‐Espiridión(5), Eulogio Conde(5), Carlos Grande(5), José Rodríguez(5), José Francisco Tomás(5)